Search - tctmd.com

Displaying 241 - 260 of 601

Sort: Relevancy | Date

News Daily News

USPSTF at Last Takes Tougher Stance on Aspirin in Primary Prevention

Shelley Wood

October 15, 2021

News Daily News

Diabetes Progression in Statin-Treated Patients: VA Data

Michael O'Riordan

October 06, 2021

News Daily News

AHA Stresses Benefit of Meds, Surgery for Obesity-Related Hypertension

Yael L. Maxwell

September 23, 2021

News Daily News

From Excess Amputations to Postpregnancy HF, Studies Shine Light on Racial Divide

L.A. McKeown

September 06, 2021

News Conference News ESC 2021

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

Michael O'Riordan

September 02, 2021

News Conference News ESC 2021

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

Michael O'Riordan

August 31, 2021

News Conference News ESC 2021

‘Quadpill’ Beats Monotherapy at BP Lowering: QUARTET

Caitlin E. Cox

August 31, 2021

News Conference News ESC 2021

Massive SSaSS Study Shows Switch to Salt Substitute Cuts Stroke, CVD

Michael O'Riordan

August 29, 2021

News Daily News

USPSTF Lowers Screening Age for Diabetes, Prediabetes to 35 for Overweight Adults

L.A. McKeown

August 25, 2021

News Conference News SCCT 2021

As New Guidelines Loom, CT Community Seeks to Fill Knowledge Gaps

Yael L. Maxwell

July 20, 2021

News Daily News

Latest Statin Risk-Benefit Analysis: More Harm Than Good?

Yael L. Maxwell

July 15, 2021

News Daily News

Making the Case for Sex-Specific CVD Guidelines

L.A. McKeown

July 08, 2021

News Daily News

OMT Boosts Survival in Revascularized Patients at 10 Years

Michael O'Riordan

June 29, 2021

News Daily News

Risk Stratification Before Noncardiac Surgery Won’t Catch All Myocardial Injury

Yael L. Maxwell

June 28, 2021

News Daily News

Statins Not Linked to Dementia or Memory Changes: ASPREE

Michael O'Riordan

June 21, 2021

News Conference News ACC 2021

New STRENGTH Analysis Revives Omega-3 Debate

Todd Neale

May 20, 2021

News Conference News ACC 2021

Evinacumab Lowers Triglycerides in Severe Hypertriglyceridemia

Yael L. Maxwell

May 16, 2021

News Conference News ACC 2021

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

Yael L. Maxwell

May 16, 2021

News Conference News ACC 2021

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

Michael O'Riordan

May 15, 2021

News Daily News

AI-ECG Allows for Early Diagnosis of Low EF

Yael L. Maxwell

May 10, 2021

Advertisement

USPSTF at Last Takes Tougher Stance on Aspirin in Primary Prevention

Diabetes Progression in Statin-Treated Patients: VA Data

AHA Stresses Benefit of Meds, Surgery for Obesity-Related Hypertension

From Excess Amputations to Postpregnancy HF, Studies Shine Light on Racial Divide

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

‘Quadpill’ Beats Monotherapy at BP Lowering: QUARTET

Massive SSaSS Study Shows Switch to Salt Substitute Cuts Stroke, CVD

USPSTF Lowers Screening Age for Diabetes, Prediabetes to 35 for Overweight Adults

As New Guidelines Loom, CT Community Seeks to Fill Knowledge Gaps

Latest Statin Risk-Benefit Analysis: More Harm Than Good?

Making the Case for Sex-Specific CVD Guidelines

OMT Boosts Survival in Revascularized Patients at 10 Years

Risk Stratification Before Noncardiac Surgery Won’t Catch All Myocardial Injury

Statins Not Linked to Dementia or Memory Changes: ASPREE

New STRENGTH Analysis Revives Omega-3 Debate

Evinacumab Lowers Triglycerides in Severe Hypertriglyceridemia

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

AI-ECG Allows for Early Diagnosis of Low EF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content